Literature DB >> 16403436

Depression of proteasome activities during the progression of cardiac dysfunction in pressure-overloaded heart of mice.

Osamu Tsukamoto1, Tetsuo Minamino, Ken-ichiro Okada, Yasunori Shintani, Seiji Takashima, Hisakazu Kato, Yulin Liao, Hidetoshi Okazaki, Mitsutoshi Asai, Akio Hirata, Masashi Fujita, Yoshihiro Asano, Satoru Yamazaki, Hiroshi Asanuma, Masatsugu Hori, Masafumi Kitakaze.   

Abstract

The ubiquitin-proteasome system contributes to regulation of apoptosis degrading apoptosis-regulatory proteins. Marked accumulation of ubiquitinated proteins in cardiomyocytes of human failing hearts suggested impaired ubiquitin-proteasome system in heart failure. Since cardiomyocyte apoptosis contributes to the progression of cardiac dysfunction in pressure-overloaded hearts, we investigated the role of ubiquitin-proteasome system in such conditions. We found that proteasome activities already depressed before the onset of cardiac dysfunction in pressure-overloaded hearts of mice. Cardiomyocyte apoptosis was observed along with depression of proteasome activities and elevation of proapoptotic/antiapoptotic protein ratio in failing hearts. In cultured cardiomyocytes, pharmacological inhibition of proteasome accumulated proapoptotic proteins such as p53 and Bax. Gene silencing of these proapoptotic proteins by RNA interference prevented the accumulation of respective proteins and attenuated cardiomyocyte apoptosis induced by proteasome inhibition. We conclude that depression of proteasome activities contributes to cardiac dysfunction resulting from cardiomyocyte apoptosis through accumulation of proapoptotic proteins by impaired degradation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16403436     DOI: 10.1016/j.bbrc.2005.12.120

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  61 in total

Review 1.  The ubiquitin-proteasome system and cardiovascular disease.

Authors:  Saul R Powell; Joerg Herrmann; Amir Lerman; Cam Patterson; Xuejun Wang
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

Review 2.  Eat your heart out: Role of autophagy in myocardial ischemia/reperfusion.

Authors:  Asa B Gustafsson; Roberta A Gottlieb
Journal:  Autophagy       Date:  2008-01-30       Impact factor: 16.016

3.  Altered ubiquitin-proteasome signaling in right ventricular hypertrophy and failure.

Authors:  Viswanathan Rajagopalan; Mingming Zhao; Sushma Reddy; Giovanni Fajardo; Xuejun Wang; Shannamar Dewey; Aldrin V Gomes; Daniel Bernstein
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-05-31       Impact factor: 4.733

Review 4.  Proteasome inhibitors and cardiac cell growth.

Authors:  Nadia Hedhli; Christophe Depre
Journal:  Cardiovasc Res       Date:  2009-07-03       Impact factor: 10.787

Review 5.  Protein quality control and degradation in cardiomyocytes.

Authors:  Xuejun Wang; Huabo Su; Mark J Ranek
Journal:  J Mol Cell Cardiol       Date:  2008-05-20       Impact factor: 5.000

Review 6.  The ubiquitin-proteasome system and nonsense-mediated mRNA decay in hypertrophic cardiomyopathy.

Authors:  Lucie Carrier; Saskia Schlossarek; Monte S Willis; Thomas Eschenhagen
Journal:  Cardiovasc Res       Date:  2009-07-17       Impact factor: 10.787

Review 7.  As time flies by: Investigating cardiac aging in the short-lived Drosophila model.

Authors:  Anna C Blice-Baum; Maria Clara Guida; Paul S Hartley; Peter D Adams; Rolf Bodmer; Anthony Cammarato
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-11-27       Impact factor: 5.187

8.  Primary proteasome inhibition results in cardiac dysfunction.

Authors:  Joerg Herrmann; Christine Wohlert; Ardan M Saguner; Ana Flores; Lisa L Nesbitt; Alejandro Chade; Lilach O Lerman; Amir Lerman
Journal:  Eur J Heart Fail       Date:  2013-04-24       Impact factor: 15.534

Review 9.  Proteasome functional insufficiency in cardiac pathogenesis.

Authors:  Xuejun Wang; Jie Li; Hanqiao Zheng; Huabo Su; Saul R Powell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-09-23       Impact factor: 4.733

Review 10.  Protein Kinase A as a Promising Target for Heart Failure Drug Development.

Authors:  Nancy S Saad; Mohammad T Elnakish; Amany A E Ahmed; Paul M L Janssen
Journal:  Arch Med Res       Date:  2019-01-11       Impact factor: 2.235

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.